Zobrazeno 1 - 10
of 246
pro vyhledávání: '"Galanis, K."'
Publikováno v:
In Ecotoxicology and Environmental Safety 2011 74(2):174-181
Autor:
I Rigopoulou E; Department of Medicine and Research Laboratory of Internal Medicine, National Expertise Center of Greece in Autoimmune Liver Diseases, General University Hospital of Larissa, Larissa 41110, Greece.; European Reference Network on Hepatological Diseases (ERN RARE-LIVER), General University Hospital of Larissa, Larissa 41110, Greece., Bakarozi M; Department of Medicine and Research Laboratory of Internal Medicine, National Expertise Center of Greece in Autoimmune Liver Diseases, General University Hospital of Larissa, Larissa 41110, Greece., Dimas I; Hepatology Outpatient Clinic, Gastroenterology Department, University Hospital Heraklion, Heraklion, Crete 70013, Greece., Galanis K; Department of Medicine and Research Laboratory of Internal Medicine, National Expertise Center of Greece in Autoimmune Liver Diseases, General University Hospital of Larissa, Larissa 41110, Greece.; European Reference Network on Hepatological Diseases (ERN RARE-LIVER), General University Hospital of Larissa, Larissa 41110, Greece., Lygoura V; Department of Medicine and Research Laboratory of Internal Medicine, National Expertise Center of Greece in Autoimmune Liver Diseases, General University Hospital of Larissa, Larissa 41110, Greece.; European Reference Network on Hepatological Diseases (ERN RARE-LIVER), General University Hospital of Larissa, Larissa 41110, Greece., K Gatselis N; Department of Medicine and Research Laboratory of Internal Medicine, National Expertise Center of Greece in Autoimmune Liver Diseases, General University Hospital of Larissa, Larissa 41110, Greece.; European Reference Network on Hepatological Diseases (ERN RARE-LIVER), General University Hospital of Larissa, Larissa 41110, Greece., Koulentaki M; Hepatology Outpatient Clinic, Gastroenterology Department, University Hospital Heraklion, Heraklion, Crete 70013, Greece., N Dalekos G; Department of Medicine and Research Laboratory of Internal Medicine, National Expertise Center of Greece in Autoimmune Liver Diseases, General University Hospital of Larissa, Larissa 41110, Greece.; European Reference Network on Hepatological Diseases (ERN RARE-LIVER), General University Hospital of Larissa, Larissa 41110, Greece.
Publikováno v:
Journal of translational internal medicine [J Transl Int Med] 2023 Sep 02; Vol. 11 (3), pp. 246-254. Date of Electronic Publication: 2023 Sep 02 (Print Publication: 2023).
Background & Aims: Recently, several risk scores for prediction of hepatocellular carcinoma (HCC) were developed in cohorts of treated Asian patients with chronic hepatitis B (CHB), but they have not been assessed in non-Asian patients. We evaluated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::cd120180691384338137548af49fd8ae
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3102336
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3102336
Background & Aims: A recent study in Asian patients with chronic hepatitis B (CHB) reported that the incidence of hepatocellular carcinoma (HCC) was lower in patients treated with tenofovir disoproxil fumarate (TDF) than entecavir (ETV), but this fin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::fa644a81470586859913b94915f81e66
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3120584
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3120584
Background & Aims: Hepatocellular carcinoma (HCC) may develop in patients with chronic hepatitis (CHB) even after 5 years of oral therapy and cannot be easily predicted. We assessed predictors of HCC development and the need for HCC surveillance in t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::5c2774ef8cc9a06a32d39212235b09c6
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3121096
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3121096
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Background & Aims: The effects of long-term antiviral therapy on survival have not been adequately assessed in chronic hepatitis B (CHB). In this 10-centre, ongoing cohort study, we evaluated the probability of survival and factors affecting survival
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::e7e1bbadcb4c6bd7c6719ded8e043238
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3123368
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3123368
Autor:
Galanis, K. P.1, Papazoglou, V. J.1
Publikováno v:
Strain. Apr2009, Vol. 45 Issue 2, p131-138. 8p. 4 Color Photographs, 7 Diagrams, 1 Chart, 3 Graphs.
Whether there is a change of hepatocellular carcinoma (HCC) incidence in chronic hepatitis B patients under long-term therapy with potent nucleos(t)ide analogues is currently unclear. We therefore assessed the HCC incidence beyond year 5 of entecavir
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::6819a984f2d6a8d46aad2b0ae42dd83e
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3125684
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3125684
Autor:
Sira, Ella Mae Joy S.1 (AUTHOR), Fajardo, Lauren Emily1 (AUTHOR), Banico, Edward C.1 (AUTHOR), Odchimar, Nyzar Mabeth O.1 (AUTHOR), Orosco, Fredmoore L.1,2,3 (AUTHOR) florosco@up.edu.ph, Nandi, Sumanta (AUTHOR)
Publikováno v:
Veterinary Medicine International. 1/3/2025, Vol. 2025, p1-20. 20p.